Tumor suppressor genes (such as p53 and PTEN) have been discovered to be epigenetically silenced in cancers to modulate autophagy to influence tumor growth, malignant and resistance to anticancer therapies[43,44]. This evidence concerns the gene TP53 and neoplasm.